Literature DB >> 25401768

Circulating endotoxaemia and frequent haemodialysis schedules.

Helen J Jefferies1, Lisa E Crowley, Laura E A Harrison, Cheuk-Chun Szeto, Philip K T Li, Brigitte Schiller, John Moran, Christopher W McIntyre.   

Abstract

BACKGROUND/AIMS: Endotoxaemia, a driver of systemic inflammation, appears to be driven by dialysis-induced circulatory stress in haemodialysis (HD) patients. More frequent HD regimens are associated with lower ultrafiltration requirements, improved haemodynamic stability and lower systemic inflammation. This study investigated the hypothesis that more frequently dialysed patients, with reduced exposure to dialysis-induced haemodynamic perturbation, would have lower circulating endotoxin (ET) levels.
METHODS: A cross-sectional study of 86 established HD patients compared three groups: conventional HD 3× per week (HD3, n = 56), frequent HD 5-6× per week (SDHD, n = 20), and nocturnal HD (NHD, n = 10). Data collection included ultrafiltration volume and rate, serial blood pressures and blood sampling with quantification of ET, troponin T and high-sensitivity CRP (hsCRP).
RESULTS: Pre-dialysis serum ET was highest in the conventional HD group (HD3 0.66 ± 0.29 EU/ml vs. NHD 0.08 ± 0.04 EU/ml). Across the study population, severity of endotoxaemia was associated with higher ultrafiltration rates, degree of intradialytic hypotension, troponin T and hsCRP levels. NHD patients had the lowest ultrafiltration requirements, the greatest haemodynamic stability and lower ET levels.
CONCLUSION: More frequent HD regimens are associated with lower levels of circulating ET compared with conventional HD. Reduced ET translocation may be related to the greater haemodynamic stability of these treatments, with superior maintenance of splanchnic perfusion.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25401768     DOI: 10.1159/000366519

Source DB:  PubMed          Journal:  Nephron Clin Pract        ISSN: 1660-2110


  11 in total

1.  The Relationship between Intradialytic Hypotension and Hospitalized Mesenteric Ischemia: A Case-Control Study.

Authors:  Eun Young Seong; Yuanchao Zheng; Wolfgang C Winkelmayer; Maria E Montez-Rath; Tara I Chang
Journal:  Clin J Am Soc Nephrol       Date:  2018-09-20       Impact factor: 8.237

Review 2.  Volume Balance and Intradialytic Ultrafiltration Rate in the Hemodialysis Patient.

Authors:  Jason A Chou; Kamyar Kalantar-Zadeh
Journal:  Curr Heart Fail Rep       Date:  2017-10

Review 3.  Development of a framework for minimum and optimal safety and quality standards for hemodialysis and peritoneal dialysis.

Authors:  Laura Sola; Nathan W Levin; David W Johnson; Roberto Pecoits-Filho; Harith M Aljubori; Yuqing Chen; Stefaan Claus; Allan Collins; Brett Cullis; John Feehally; Paul N Harden; Mohamed H Hassan; Fuad Ibhais; Kamyar Kalantar-Zadeh; Adeera Levin; Abdulkarim Saleh; Daneil Schneditz; Irma Tchokhonelidze; Rumeyza Turan Kazancioglu; Ahmed Twahir; Robert Walker; Anthony J O Were; Xueqing Yu; Fredric O Finkelstein
Journal:  Kidney Int Suppl (2011)       Date:  2020-02-19

Review 4.  Rapid ultrafiltration rates and outcomes among hemodialysis patients: re-examining the evidence base.

Authors:  Magdalene M Assimon; Jennifer E Flythe
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-11       Impact factor: 2.894

5.  Circulating Bacterial Fragments as Cardiovascular Risk Factors in CKD.

Authors:  Cheuk-Chun Szeto; Christopher William McIntyre; Philip Kam-Tao Li
Journal:  J Am Soc Nephrol       Date:  2018-04-17       Impact factor: 10.121

6.  Exploring the Link Between Hepatic Perfusion and Endotoxemia in Hemodialysis.

Authors:  Raanan Marants; Elena Qirjazi; Ka-Bik Lai; Cheuk-Chun Szeto; Philip K T Li; Fiona Li; Ting-Yim Lee; Christopher W McIntyre
Journal:  Kidney Int Rep       Date:  2021-02-09

7.  A comparative study of blood endotoxin detection in haemodialysis patients.

Authors:  Jonathan Wong; Nathan Davies; Hasan Jeraj; Enric Vilar; Adie Viljoen; Ken Farrington
Journal:  J Inflamm (Lond)       Date:  2016-07-30       Impact factor: 4.981

8.  Is Endotoxemia in Stable Hemodialysis Patients an Artefact? Limitations of the Limulus Amebocyte Lysate Assay and Role of (1→3)-β-D Glucan.

Authors:  Jonathan Wong; Yonglong Zhang; Ashish Patidar; Enric Vilar; Malcolm Finkelman; Ken Farrington
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

Review 9.  Intestinal Barrier Disturbances in Haemodialysis Patients: Mechanisms, Consequences, and Therapeutic Options.

Authors:  D S March; M P M Graham-Brown; C M Stover; N C Bishop; J O Burton
Journal:  Biomed Res Int       Date:  2017-01-17       Impact factor: 3.411

10.  Impaired Gut Epithelial Tight Junction Expression in Hemodialysis Patients Complicated with Intradialytic Hypotension.

Authors:  Tsai-Kun Wu; Paik-Seong Lim; Jong-Shiaw Jin; Ming-Ying Wu; Chang-Hsu Chen
Journal:  Biomed Res Int       Date:  2018-01-16       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.